Dados B3 › MATD3 × RDOR3
MATD3 × RDOR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | MATD3 | RDOR3 | year |
|---|---|---|---|
| ROE | 7.6% | 21.3% | 2025 |
| ROIC | 10.6% | 29.7% | 2025 |
| ROA | 2.6% | 4.6% | 2025 |
| Gross margin | 29.9% | 21.9% | 2025 |
| EBIT margin | 16.3% | 17.7% | 2025 |
| Net margin | 5.1% | 8.7% | 2025 |
| Net debt/EBITDA | 1.67x | 0.48x | 2025 |
| Current ratio | 3.04x | 2.79x | 2025 |
| Revenue growth (1y) | -2.3% | 10.2% | 2025 |
| Revenue growth (5y CAGR) | 24.8%! | 31.8% | 2025 |
| Piotroski F-Score | 6/9 | 6/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | MATD3 | RDOR3 | year |
|---|---|---|---|
| P/E | 17.43x | 20.48x | 2025 |
| P/B | 1.32x | 4.96x | 2025 |
| EV/EBITDA | 5.82x | 8.68x | 2025 |
| FCF yield | 8.5% | -2.9% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:25 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:25 UTC. If this does not match /saude, you are reading a cached copy.